Nanotechnology and Antivirus Nanomaterials for Combating COVID-19 : Strategies against SARS-CoV-2 Variants in the Post-pandemic Era (Micro & Nano Technologies)

個数：

予約

Nanotechnology and Antivirus Nanomaterials for Combating COVID-19 : Strategies against SARS-CoV-2 Variants in the Post-pandemic Era (Micro & Nano Technologies)

Chen, Jen-Tsung (EDT)

ウェブストア価格 ¥43,464（本体¥39,513）
Elsevier - Health Sciences Division（2025/12発売）
外貨定価 US$ 210.00
ポイント 395pt

現在予約受付中です。出版後の入荷・発送となります。
（重要：表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。）

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 420 p.
言語 ENG
商品コード 9780443330025

Full Description

Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable resource for researchers, scientists, and professionals seeking a deeper understanding of nanotechnology's applications for preventing, diagnosing, and managing COVID-19.

1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating SARS-CoV-2 variants
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature's arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases